Finding new cell markers to track the most aggressive breast cancer in blood

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

Blood test predicts which patients with lung cancer will benefit from newly approved immunotherapy drug

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
News-Medical.Net

Novel antibody shows promise in overcoming resistance to cancer immunotherapy

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the ...

Blood test flags digestive disease risk years before symptoms appear

Canadian researchers say a blood test measuring immune response to gut bacteria could help predict Crohn’s disease years ...
Science Daily

This 15 minute hepatitis C test could change everything

Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes. The test uses the DASH rapid PCR system, originally developed for COVID, ...
Investing

Pyxis Oncology stock falls as RBC cuts price target on complex trial data

Investing.com - Pyxis Oncology Inc. (NASDAQ:PYXS) shares declined after RBC Capital lowered its price target to $5.00 from $8.00 while maintaining an Outperform rating. The adjustment follows Pyxis ...